Extendicare (TSE:EXE) Given a C$11.00 Price Target by BMO Capital Markets Analysts

Extendicare (TSE:EXE) received a C$11.00 price objective from equities research analysts at BMO Capital Markets in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 6.28% from the company’s previous close.

Several other research firms have also recently issued reports on EXE. Royal Bank of Canada upped their price target on Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th. TD Securities boosted their price objective on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th.

Extendicare Stock Performance

EXE stock opened at C$10.35 on Thursday. The company has a 50-day simple moving average of C$10.36 and a 200 day simple moving average of C$9.21. The company has a market capitalization of C$863.91 million, a P/E ratio of 15.22 and a beta of 1.26. The company has a quick ratio of 0.98, a current ratio of 0.60 and a debt-to-equity ratio of 305.80. Extendicare has a fifty-two week low of C$6.63 and a fifty-two week high of C$10.89.

Extendicare (TSE:EXE) last released its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. During the same period in the prior year, the business earned $0.13 earnings per share. Sell-side analysts predict that Extendicare will post 0.6134729 earnings per share for the current fiscal year.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.